SS
TDACW

Steve Schonfeld’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Steve Schonfeld’s Portfolio TDACW Stock Details TDACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,892
Closed -$2.79K – 3123
2026
Q1 		$2.79K Hold
19,892
– – ﹤0.01% 2137
2025
Q4 		$5.87K Sell
19,892
-1,858
-9% -$609 ﹤0.01% 1970
2025
Q3 		$6.31K Sell
21,750
-800
-4% -$217 ﹤0.01% 2136
2025
Q2 		$6.56K Buy
22,550
+12,550
+126% +$2.59K ﹤0.01% 1959
2025
Q1 		$2.55K Buy
+10,000
New +$1.76K ﹤0.01% 2147

Other funds holding TDACW

LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return

Steve Schonfeld's TDACW Position: Q2 2026 in Review

Steve Schonfeld sold out of Translational Development Acquisition Corp Warrants (TDACW) in Q2 2026, closing a stake of 19,892 shares — an estimated $2.79K sold.

Steve Schonfeld first reported a position in TDACW in Q1 2025 and held it in 5 quarters. The position peaked at $6.56K in Q2 2025. 28 funds tracked by Wall St. Rank hold TDACW as of Q2 2026.

  • Steve Schonfeld reported no remaining Translational Development Acquisition Corp Warrants position as of Q2 2026 after selling out during the quarter.
  • Steve Schonfeld sold 19,892 Translational Development Acquisition Corp Warrants shares in Q2 2026, an estimated $2.79K.
  • Steve Schonfeld first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and held it in 5 quarters.
  • Steve Schonfeld's Translational Development Acquisition Corp Warrants position peaked at $6.56K in Q2 2025.
  • 28 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.